Genetic and epigenetic analyses of panic disorder in the post-GWAS era
Autor: | Akira Imamura, Yoshiro Morimoto, Naohiro Kurotaki, Hiroki Ozawa, Shinji Ono |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Psychiatry and Preclinical Psychiatric Studies - Review Article Genome-wide association study Computational biology Epigenesis Genetic 03 medical and health sciences 0302 clinical medicine Missing heritability problem medicine Humans Genetic Predisposition to Disease Epigenetics Genome-wide association studies (GWAS) Biological Psychiatry Genetic association Panic disorder Next-generation sequencing (NGS) business.industry Rare variant association study (RVAS) Panic Missing heritability medicine.disease Psychiatry and Mental health 030104 developmental biology Neurology Epigenome-wide association study (EWAS) Anxiety Identification (biology) Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery Genome-Wide Association Study |
Zdroj: | Journal of Neural Transmission |
ISSN: | 1435-1463 0300-9564 |
Popis: | Panic disorder (PD) is a common and debilitating neuropsychiatric disorder characterized by panic attacks coupled with excessive anxiety. Both genetic factors and environmental factors play an important role in PD pathogenesis and response to treatment. However, PD is clinically heterogeneous and genetically complex, and the exact genetic or environmental causes of this disorder remain unclear. Various approaches for detecting disease-causing genes have recently been made available. In particular, genome-wide association studies (GWAS) have attracted attention for the identification of disease-associated loci of multifactorial disorders. This review introduces GWAS of PD, followed by a discussion about the limitations of GWAS and the major challenges facing geneticists in the post-GWAS era. Alternative strategies to address these challenges are then proposed, such as epigenome-wide association studies (EWAS) and rare variant association studies (RVAS) using next-generation sequencing. To date, however, few reports have described these analyses, and the evidence remains insufficient to confidently identify or exclude rare variants or epigenetic changes in PD. Further analyses are therefore required, using sample sizes in the tens of thousands, extensive functional annotations, and highly targeted hypothesis testing. |
Databáze: | OpenAIRE |
Externí odkaz: |